Association between depth of response (DepOR) and overall survival (OS): Exploratory analysis of nivolumab plus ipilimumab (N plus I) vs sunitinib (S) in patients with previously untreated advanced renal cell carcinoma (ARCC) in Checkmate 214 Meeting Abstract


Authors: Gruenwald, V.; Choueiri, T. K.; Rini, B. I.; Powles, T.; George, S.; Grimm, M. O.; McHenry, M. B.; Maurer, M.; Motzer, R. J.; Hammers, H. J.; Tannir, N. M.; Albiges, L.
Abstract Title: Association between depth of response (DepOR) and overall survival (OS): Exploratory analysis of nivolumab plus ipilimumab (N plus I) vs sunitinib (S) in patients with previously untreated advanced renal cell carcinoma (ARCC) in Checkmate 214
Meeting Title: 34. Deutscher Krebskongress (DKK)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 1
Meeting Dates: 2020 Feb 19-22
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-02-01
Start Page: 74
End Page: 75
Language: English
ACCESSION: WOS:000517158700180
PROVIDER: wos
DOI: 10.1159/000506491
Notes: "34th German Cancer Congress" -- Meeting Abstract: 323 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1248 Motzer